UK Committee Criticizes Palantir NHS Contract
Analysis based on 6 articles · First reported Jun 02, 2026 · Last updated Jun 03, 2026
The report from the United Kingdom — Science, Innovation and Technology Committee>>> could negatively impact Palantir>>>'s stock price due to the potential cancellation of its significant £330 million contract with the United Kingdom — National Health Service>>>. It also highlights broader concerns about the United Kingdom>>>'s digital strategy and reliance on foreign tech, which could affect other US tech companies operating in the UK public sector.
A parliamentary committee in the United Kingdom>>> has issued a critical report, singling out US tech group Palantir>>> as an 'unacceptable point of weakness' due to Britain's over-reliance on US companies in the public sector. The report urges the government to exercise a break clause in Palantir>>>'s £330 million contract with the United Kingdom — National Health Service>>>, citing a 'clear mismatch with UK values' and potential vendor lock-in. Concerns were raised about Palantir>>>'s supply of software to the US military and immigration services, as well as the political views of its co-founder, Peter Thiel>>>. While Palantir>>>'s British CEO, Louis Mosley>>>, defended the contract as delivering and its cancellation 'irresponsible', non-profit Digitalis>>> welcomed the report and called for the contract's termination. The committee also criticized the government's lack of a coherent digital transformation plan for public services.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard